Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study.

Cook JR, Goldman B, Tubbs RR, Rimsza L, Leblanc M, Stiff P, Fisher R.

Am J Surg Pathol. 2014 Apr;38(4):494-501. doi: 10.1097/PAS.0000000000000147.

2.

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.

Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.

3.

Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.

B├╝rgesser MV, Gualco G, Diller A, Natkunam Y, Bacchi CE.

Ann Diagn Pathol. 2013 Jun;17(3):250-5. doi: 10.1016/j.anndiagpath.2012.11.001. Epub 2012 Dec 14.

PMID:
23246412
4.

Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.

Gualco G, Weiss LM, Harrington WJ Jr, Bacchi CE.

Am J Surg Pathol. 2009 Dec;33(12):1815-22. doi: 10.1097/PAS.0b013e3181bb9a18.

5.

C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas.

Huang W, Guo L, Liu H, Zheng B, Ying J, Lv N.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5634-44. eCollection 2014.

6.

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.

Swerdlow SH.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):90-9. doi: 10.1182/asheducation-2014.1.90. Epub 2014 Nov 18. Review.

PMID:
25696840
7.

Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.

Wang W, Hu S, Lu X, Young KH, Medeiros LJ.

Am J Surg Pathol. 2015 Aug;39(8):1132-9. doi: 10.1097/PAS.0000000000000434.

PMID:
25828391
8.

Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.

Xia B, Zhang L, Guo SQ, Li XW, Qu FL, Zhao HF, Zhang LY, Sun BC, You J, Zhang YZ.

World J Gastroenterol. 2015 Feb 28;21(8):2433-42. doi: 10.3748/wjg.v21.i8.2433.

9.

[B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].

Luo DL, Liu YH, Zhang F, Xu FP, Yan LX, Chen J, Xu J, Luo XL, Zhuang HG.

Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):584-8. Chinese.

PMID:
24314242
10.

[Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].

Zhou J, Xia C, Shen Q, Yin H, Zhang X, Shi Q, Zhou X, Ma J.

Zhonghua Bing Li Xue Za Zhi. 2014 Jan;43(1):8-14. Chinese.

PMID:
24713242
11.

Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.

Oh EJ, Yang WI, Cheong JW, Choi SE, Yoon SO.

Hum Pathol. 2014 Oct;45(10):2043-50. doi: 10.1016/j.humpath.2014.07.002. Epub 2014 Jul 23.

PMID:
25149548
12.

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.

Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ, Siebert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE.

Blood. 2009 Sep 10;114(11):2273-9. doi: 10.1182/blood-2009-03-212191. Epub 2009 Jul 13.

13.

Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.

Agarwal R, Lade S, Liew D, Rogers TM, Byrne D, Feleppa F, Juneja S, Westerman DA.

J Clin Pathol. 2016 Mar;69(3):266-70. doi: 10.1136/jclinpath-2015-203002. Epub 2015 Aug 25.

PMID:
26307073
14.

High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.

Li S, Weiss VL, Wang XJ, Desai PA, Hu S, Yin CC, Tang G, Reddy NM, Medeiros LJ, Lin P.

Am J Surg Pathol. 2016 Feb;40(2):253-61. doi: 10.1097/PAS.0000000000000542.

PMID:
26448193
15.

Clinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern India.

Selvi SK, Kar R, Basu D, Jacob SE, Dubashi B.

Indian J Hematol Blood Transfus. 2016 Jun;32(2):168-75. doi: 10.1007/s12288-015-0558-6. Epub 2015 May 30.

PMID:
27065578
16.

Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.

Seegmiller AC, Garcia R, Huang R, Maleki A, Karandikar NJ, Chen W.

Mod Pathol. 2010 Jul;23(7):909-20. doi: 10.1038/modpathol.2010.76. Epub 2010 Mar 26.

17.

Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.

McClure RF, Remstein ED, Macon WR, Dewald GW, Habermann TM, Hoering A, Kurtin PJ.

Am J Surg Pathol. 2005 Dec;29(12):1652-60.

PMID:
16327438
18.

MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system.

Gill KZ, Iwamoto F, Allen A, Hoehn D, Murty VV, Alobeid B, Bhagat G.

PLoS One. 2014 Dec 5;9(12):e114398. doi: 10.1371/journal.pone.0114398. eCollection 2014.

19.

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ.

Mod Pathol. 2012 Jan;25(1):145-56. doi: 10.1038/modpathol.2011.147. Epub 2011 Oct 14.

20.

miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

Zajdel M, Rymkiewicz G, Chechlinska M, Blachnio K, Pienkowska-Grela B, Grygalewicz B, Goryca K, Cieslikowska M, Bystydzienski Z, Swoboda P, Walewski J, Siwicki JK.

Tumour Biol. 2015 Jul;36(7):5377-88. doi: 10.1007/s13277-015-3203-y. Epub 2015 Feb 13.

PMID:
25677902

Supplemental Content

Support Center